Albumin Market Is Predicted To Grow At A CAGR Of 6.12% Due To Rise In Rare Medical Cases Along With Non-Therapeutic Use Of Albumin

According to the report, the global albumin market size was valued at approximately USD 6.42 billion in 2024 and is projected to reach around USD 11.63 billion by the end of 2034, expanding at a CAGR of approximately 6.12% from 2025 to 2034. The report analyzes the global albumin market's drivers, restraints/challenges, and their effects on demand during the projection period. In addition, the report explores emerging opportunities in the albumin industry.

Industry Overview:

Albumin is a family of water-soluble globular proteins found in the human body. Albumin is created in the body by the liver; lower levels of it indicate liver or kidney problems. Albumin is a carrier of other important components like enzymes, vitamins, and hormones throughout the body and helps in volumizing blood flow. It is used in the treatment of a variety of diseases including diabetes, cancer, trauma, renal dialysis, liver diseases, acute respiratory distress, nephrosis, and hepatitis.

Browse the full “Albumin Market By Product (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), By Application (Therapeutics, Diagnostics, Drug Delivery, Vaccine Ingredient, Culture Medium Ingredient & Stabilizer, In-Vitro Fertilization, and Others), By End-User (Pharmaceutical & Biotechnology Industry, Research Institutes, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034” - Report at https://www.zionmarketresearch.com/report/albumin-market

Industry Growth Drivers:

With advancements in technology, the detection of rare diseases that can be effectively treated with albumin has increased. This is projected to instill a rise in the global market value of albumin. The extensive use of albumin in vaccine preparation is expected to boost the global market during the forecast period. The growing awareness of recombinant albumin products and their benefits is expected to become a chief global market driver during the projection period. Furthermore, the rise in competition and subsequent expansion of companies in the global market is expected to push global market growth.

Restraints:

An increase in the irrational use of albumin is anticipated to restrain the global albumin market growth during the forecast period. Irrational use includes hypoproteinemia and nutritional support. This is caused by a non-essential or unsuitable prescription of albumin. Adverse reactions like ankle and leg swelling, itching or skin rash, breathing difficulties, and discoloration of lips and fingertips due to albumin-related products are anticipated to restrain the global market growth. The global market is witnessing a rise in demand for serum-free solutions given the lower risk of contamination in serum-free solutions along with easier purification. The shift in preference is anticipated to act as a restraining agent in the global market.

Market Segmentation:

The albumin market is segmented based on product, application, end-user, and region.

Based on Product, the albumin market is divided into human serum albumin, bovine serum albumin, recombinant albumin, and others. Human serum albumin is expected to lead the global market as the most dominant segment due to its rich composition, widespread clinical applications, and cost-effectiveness in therapeutic use. This dominance drives overall market growth by supporting high-volume demand in critical care and chronic disease management, fostering continuous innovation in purification technologies, reinforcing trends toward human-derived biologics, and enabling expansion into emerging therapeutic areas. Bovine serum albumin represents the second most dominant segment, valued for its utility in research and diagnostic applications that complement clinical demand.

Based on Application, the albumin market is divided into therapeutics, diagnostics, drug delivery, vaccine ingredients, culture medium ingredients and stabilizers, in-vitro fertilization, and others. Therapeutics is growing at a high rate and will continue to dominate the global market as the most dominant segment owing to extensive use in treating trauma, burns, liver diseases, and other critical conditions. This dominance drives overall market growth by generating consistent clinical demand, stimulating advancements in formulation stability, supporting trends in personalized medicine, and expanding applications across hospital and specialty care settings. Vaccine ingredients follow as the second most dominant segment, benefiting from rising immunization needs and biopharmaceutical manufacturing requirements.

Based on End-User, the albumin market is divided into the pharmaceutical and biotechnology industry, research institutes, and others. The pharmaceutical and biotechnology industry is projected to swipe the largest market share as the most dominant segment, driven by rising drug development activities and large-scale production needs. This dominance drives overall market growth by concentrating demand for high-purity albumin in manufacturing processes, encouraging investment in advanced production capabilities, supporting innovation in recombinant alternatives, and accelerating industry expansion through strategic collaborations and capacity building. Research institutes represent the second most dominant segment, contributing through ongoing scientific investigations and diagnostic applications.

North America & Europe to dominate the global market

North America and Europe are predicted to dominate the global market during the forecast period because of greater awareness and acceptance of the drugs. These regions have a high per capita capacity for medical expenditure and are expected to carry the same growing trend in the global market during the projection period. This regional leadership drives overall market growth by establishing advanced clinical standards, attracting substantial research and development investments, accelerating the adoption of innovative albumin formulations, and influencing global trends toward evidence-based therapeutic applications that expand market sophistication and accessibility.

Industry Key Players:

Leading companies operating in the global albumin market include:

• Baxter International Inc.
• Akron Biotech
• Octapharma AG
• HiMedia Laboratories Pvt. Ltd.
• Grifols, SA
• Takeda Pharmaceuticals Inc
• Mitsubishi Tanabe Pharma Corporation
• Merck KGaA
• Thermo Fisher Scientific Inc.
• China Biologic Products Inc
• Sigma-Aldrich Co.
• And others

Recent Developments

• In March 2020, FDA approved the use of the Pumotech MAA kit for Curium Pharma. The kit is used to prepare technetium Tc 99m Albumin aggregated injection. The injection is used for lung imaging and evaluation of pulmonary perfusion. The injection acts as a single-photon emission agent.
• May 2020 witnessed the announcement by Bio Products Laboratory for the US launch of Albuminex 5% and Albuminex 25% solutions to be used for injection. The injection is FDA-approved and is used in treatment related to burns, cardiopulmonary bypass, acute nephrosis, and ARDS.

The global albumin market is segmented as follows:

By Product

• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin

By Application

• Therapeutics
• Diagnostics
• Drug Delivery
• Vaccine ingredient
• Culture Medium
• Ingredient & Stabilizer
• In-vitro Fertilization

By End-User

• Pharmaceutical & Biotechnology Industry
• Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com